Actively Recruiting
Total Intravenous Anesthesia and Recurrence Free Survival
Led by The Cleveland Clinic · Updated on 2024-12-04
1614
Participants Needed
1
Research Sites
380 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators propose to compare recurrence-free survival in patients having potentially curative (Stages 1-3) surgery for esophageal cancer who will be randomly assigned to propofol-based total intravenous anesthesia or sevoflurane-based balanced general anesthesia.
CONDITIONS
Official Title
Total Intravenous Anesthesia and Recurrence Free Survival
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary esophageal cancer without known extension beyond the esophagus (Tumor Stage 1-3)
- Scheduled for potentially curative esophageal cancer surgery
- Provided written informed consent and agree to be randomized to intravenous versus volatile anesthesia
You will not qualify if you...
- Previous surgery for esophageal cancer except diagnostic biopsies
- Age below 18 or above 85 years
- ASA Physical Status 4 or higher
- Any contraindication to propofol or sevoflurane
- Other cancer not believed to be in long-term remission
- Systemic disease with estimated 25% or higher two-year mortality according to the attending surgeon
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanhai Chest Hospital
Shanghai, China
Actively Recruiting
Research Team
D
Daniel I Sessler, MD
CONTACT
F
Fabio Rodriquez Patarroyo, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here